Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

P237 Tonsil Carcinoma Treated by Transoral Laser Microsurgery, II: Persistent, Recurrent, and Second Primary Tumors

P237 Tonsil Carcinoma Treated by Transoral Laser Microsurgery, II: Persistent, Recurrent, and... Objective: To report the oncologic outcomes of transoral laser microsurgery (TLM) in the treatment of persistent, recurrent, and second primary squamous cell carcinoma of the tonsil. Design: A 2-center prospective case series analysis of TLM in the treatment of tonsil carcinoma. Setting: Academic tertiary referral centers. Patients: Twenty-three patients were treated with TLM between 1996 and 2005. Sixteen of these were TX NX with persistent or locally recurrent disease at a previously treated primary site. The estimated T stage of these patients was T1, 5; T2, 6; T3, 4; and T4, 1. Seven of the 23 patients had second primary tumors within previously treated fields staged as follows: T1, 3; T2, 3; and T3 1. Previous treatment included radiotherapy, chemotherapy, surgery, or a combination of some or all of these. Neck dissections were performed in 9 of 23 patients. Three of 23 patients received postoperative radiotherapy. Median follow-up was 14 months; mean, 23 months; range, 1 to 71 months. Interventions: Transoral laser microsurgery with or without neck dissection, adjuvant radiotherapy, or adjuvant chemotherapy. Main Outcome Measures: Local and locoregional control and recurrence-free and overall survival. Results: The 5-year Kaplan-Meier estimates were as follows: local control, 98%; recurrence-free survival, 81%; and overall survival, 78%. The average duration of hospital stay was 2 days. Three patients (13%) experienced postoperative hemorrhage. Conclusions: Transoral laser microsurgery is a safe and effective treatment for select persistent, recurrent, and second primary squamous cell carcinoma of the tonsil. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Otolaryngology - Head & Neck Surgery American Medical Association

P237 Tonsil Carcinoma Treated by Transoral Laser Microsurgery, II: Persistent, Recurrent, and Second Primary Tumors

Loading next page...
 
/lp/american-medical-association/p237-tonsil-carcinoma-treated-by-transoral-laser-microsurgery-ii-akUQ2Ecd44
Publisher
American Medical Association
Copyright
Copyright © 2006 American Medical Association. All Rights Reserved.
ISSN
0886-4470
eISSN
1538-361X
DOI
10.1001/archotol.132.8.911-c
Publisher site
See Article on Publisher Site

Abstract

Objective: To report the oncologic outcomes of transoral laser microsurgery (TLM) in the treatment of persistent, recurrent, and second primary squamous cell carcinoma of the tonsil. Design: A 2-center prospective case series analysis of TLM in the treatment of tonsil carcinoma. Setting: Academic tertiary referral centers. Patients: Twenty-three patients were treated with TLM between 1996 and 2005. Sixteen of these were TX NX with persistent or locally recurrent disease at a previously treated primary site. The estimated T stage of these patients was T1, 5; T2, 6; T3, 4; and T4, 1. Seven of the 23 patients had second primary tumors within previously treated fields staged as follows: T1, 3; T2, 3; and T3 1. Previous treatment included radiotherapy, chemotherapy, surgery, or a combination of some or all of these. Neck dissections were performed in 9 of 23 patients. Three of 23 patients received postoperative radiotherapy. Median follow-up was 14 months; mean, 23 months; range, 1 to 71 months. Interventions: Transoral laser microsurgery with or without neck dissection, adjuvant radiotherapy, or adjuvant chemotherapy. Main Outcome Measures: Local and locoregional control and recurrence-free and overall survival. Results: The 5-year Kaplan-Meier estimates were as follows: local control, 98%; recurrence-free survival, 81%; and overall survival, 78%. The average duration of hospital stay was 2 days. Three patients (13%) experienced postoperative hemorrhage. Conclusions: Transoral laser microsurgery is a safe and effective treatment for select persistent, recurrent, and second primary squamous cell carcinoma of the tonsil.

Journal

Archives of Otolaryngology - Head & Neck SurgeryAmerican Medical Association

Published: Aug 1, 2006

Keywords: neoplasms

There are no references for this article.